Search
Embramine H1-Antihistamine Action
smpdb.ca/view/SMP0062622Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Drugs: CalciumEnzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaThenyldiamine H1-Antihistamine Action
smpdb.ca/view/SMP0062624Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Drugs: CalciumEnzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaPropiomazine H1-Antihistamine Action
smpdb.ca/view/SMP0062625Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaClocinizine H1-Antihistamine Action
smpdb.ca/view/SMP0062788Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Drugs: CalciumEnzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaAlcaftadine H1-Antihistamine Action
smpdb.ca/view/SMP0062881Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaPimethixene H1-Antihistamine Action
smpdb.ca/view/SMP0062886Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaDexbrompheniramine H1-Antihistamine Action
smpdb.ca/view/SMP0057580Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaDimetindene H1-Antihistamine Action
smpdb.ca/view/SMP0057582Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaHistapyrrodine H1-Antihistamine Action
smpdb.ca/view/SMP0058732Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaThonzylamine H1-Antihistamine Action
smpdb.ca/view/SMP0058769Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alpha